Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ACADEMIA
ACADEMIA
- Inlyta Can Be 1st-Choice in 2nd-Line Therapy: Prof. Uemura of Kinki Univ.
July 13, 2012
- Minirinmelt Most Effective for Nocturnal Enuresis, But Precaution for Water Intoxication Needed: Prof. Kaneko
July 11, 2012
- Drug Damage Watchdog Calls for Halt to Easing of Safety Management Procedures for Thalidomide
June 28, 2012
- Univ. of Tokyo Hospital’s New “Phase I Unit” to Initiate Trials for Takeda’s TAK-070 for AD
June 28, 2012
- JSGM Discuss Prices for Long-Listed Products and GEs, Say Unified Prices Could Ruin GE Business
June 26, 2012
- RIKEN, NCC Succeed at Visualizing Kinetics of Trastuzumab in HER2-Positive Breast Cancer Patients
June 7, 2012
- JSN Revises CKD Guidelines; Changes Severity Classifications
May 31, 2012
- Serious ADR for Abatacept shows 2.4%, Lower Than Other RA Drugs: All-Case PMS Interim Analysis
May 7, 2012
- St. Marianna University School of Medicine Hospital to Introduce CDTM, Protocols for Pharmacists to Determine Prescriptions
April 27, 2012
- Remission Rate Equal in Antirheumatic Drugs, Anti-TNF Drugs in JaSTAR’s Interim Analysis
April 26, 2012
- Adoption of NGSP Values for HbA1c Measurement to “Enable Japan’s Leadership in Clinical Trials”: Prof. Kadowaki
April 10, 2012
- Generic Name Prescriptions Rapidly Rise on New Premium, Tokyo Pharmaceutical Association Issues Warning
April 9, 2012
- Industry-Academia-Government Research Group to Build Adjuvant Database, Support Next-Generation Vaccine Development
March 29, 2012
- Prof. Nakamura Renews Call for Establishment of Drug Discovery Support Organization
March 9, 2012
- Insulin Stockpiles Insufficient at Medical Facilities in Disaster-Hit Areas: JDS Survey
March 6, 2012
- Osaka Medical Center President Hori says “Once-Daily Xarelto is Easy to Take”
February 27, 2012
- JAS 2012 GL Calls for Consideration of Medication for Primary Prevention in Patients with LDL-C Levels Over 180 mg/dL
February 7, 2012
- Demand for Celecox Expected to Increase for Acute Pain Relief: Prof. Ishiguro
January 26, 2012
- Manufacturers Report on Patient Benefits of Oral RI Drugs
January 24, 2012
- JDS to Use NGPS Score for HbA1c in Clinical Practices from April
January 23, 2012
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…